{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:22:20Z","timestamp":1790558540536,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012390","name":"Swiss Research Initiative in Systems Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["694033 STEM-BCPC"],"award-info":[{"award-number":["694033 STEM-BCPC"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_184673 20"],"award-info":[{"award-number":["310030_184673 20"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006069","name":"Krebsliga Beider Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.xcrm.2023.101002","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T10:52:08Z","timestamp":1681210328000},"page":"101002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["N-acetylcysteine overcomes NF1 loss-driven resistance to PI3K\u03b1 inhibition in breast cancer"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9059-8979","authenticated-orcid":false,"given":"Priska","family":"Auf der Maur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel P.","family":"Trefny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Vulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luisa","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Diepenbruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan-Tiberius","family":"Preca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Eichlisberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Buczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Rugaard","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Zippelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6344-1127","authenticated-orcid":false,"given":"Mohamed","family":"Bentires-Alj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101002_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2023.101002_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s43018-021-00181-0","article-title":"Emerging strategies for treating metastasis","volume":"2","author":"Esposito","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2023.101002_bib3","doi-asserted-by":"crossref","first-page":"e14283","DOI":"10.15252\/emmm.202114283","article-title":"Feed-forward loops between metastatic cancer cells and their microenvironment\u2014the stage of escalation","author":"Baumann","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2023.101002_bib4","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1038\/onc.2014.314","article-title":"Mechanism-based cancer therapy: resistance to therapy, therapy for resistance","volume":"34","author":"Ramos","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2023.101002_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/bcr3039","article-title":"Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer","volume":"13","author":"Miller","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Fulton","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101002_bib7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1158\/1535-7163.MCT-13-0865","article-title":"Characterization of the novel and specific PI3Ka inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials","volume":"13","author":"Fritsch","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2023.101002_bib8","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA -mutated, hormone receptor\u2013positive advanced breast cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.101002_bib9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/cancers13071538","article-title":"Mechanisms of resistance to pi3k inhibitors in cancer: adaptive responses, drug tolerance and cellular plasticity","volume":"13","author":"Wright","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2023.101002_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41573-021-00209-1","article-title":"PI3K inhibitors are finally coming of age","volume":"20","author":"Vanhaesebroeck","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2023.101002_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature13948","article-title":"Convergent loss of PTEN leads to clinical resistance to a PI(3)K\u03b1 inhibitor","volume":"518","author":"Juric","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101002_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/BST20140034","article-title":"Anticipating mechanisms of resistance to PI3K inhibition in breast cancer: a challenge in the era of precision medicine","volume":"42","author":"Leroy","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.xcrm.2023.101002_bib13","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","article-title":"Suppression of feedback loops mediated by pi3k\/mtor induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance","volume":"13","author":"Rozengurt","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2023.101002_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101002_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1158\/2159-8290.CD-18-1175","article-title":"Challenges for the clinical development of PI3K inhibitors: strategies to improve their impact in solid tumors","volume":"9","author":"Hanker","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101002_bib16","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1126\/science.1193004","article-title":"PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice","volume":"330","author":"Rad","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101002_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.3164","article-title":"A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer","volume":"47","author":"Rad","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2023.101002_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13059-015-0794-y","article-title":"The utility of transposon mutagenesis for cancer studies in the era of genome editing","volume":"16","author":"DeNicola","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2023.101002_bib19","doi-asserted-by":"crossref","first-page":"e13162","DOI":"10.15252\/emmm.202013162","article-title":"The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells","volume":"13","author":"Zilli","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2023.101002_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13059-020-02118-9","article-title":"CRISPR and transposon in\u00a0vivo screens for cancer drivers and therapeutic targets","volume":"21","author":"Noorani","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2023.101002_bib21","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1158\/0008-5472.CAN-10-3827","article-title":"Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors","volume":"71","author":"Meyer","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0092-8674(92)90407-4","article-title":"Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis","volume":"69","author":"DeClue","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101002_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/356713a0","article-title":"Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients","volume":"356","author":"Basu","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101002_bib24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng0296-144","article-title":"Erratum: loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells (Nature Genetics (1996) 12 (144-148))","volume":"12","author":"Bollag","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2023.101002_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.4573","article-title":"Genomic landscape of adenoid cystic carcinoma of the breast","volume":"237","author":"Martelotto","year":"2015","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.xcrm.2023.101002_bib26","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cell.2020.10.036","article-title":"Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy","volume":"183","author":"Krug","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101002_bib27","doi-asserted-by":"crossref","first-page":"100525","DOI":"10.1016\/j.xcrm.2022.100525","article-title":"An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer","volume":"3","author":"Johnson","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2023.101002_bib28","doi-asserted-by":"crossref","first-page":"e1002201","DOI":"10.1371\/journal.pmed.1002201","article-title":"Mutational profile of metastatic breast cancers: a retrospective analysis","volume":"13","author":"Lefebvre","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.xcrm.2023.101002_bib29","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1038\/s41467-021-27093-y","article-title":"HER2\u00a0+ breast cancers evade anti-HER2 therapy via a switch in driver pathway","volume":"12","author":"Smith","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101002_bib30","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1038\/ncomms11479","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101002_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101002_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41523-019-0126-6","article-title":"PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer","volume":"5","author":"Nixon","year":"2019","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.xcrm.2023.101002_bib33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101002_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s43018-020-0047-1","article-title":"Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors","volume":"1","author":"Razavi","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2023.101002_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/2159-8290.CD-20-1726","article-title":"INK4 tumor suppressor proteins mediate resistance to CDK4\/6 kinase inhibitors","volume":"12","author":"Li","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101002_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","article-title":"The genomic landscape of endocrine-resistant advanced breast cancers","volume":"34","author":"Razavi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101002_bib37","doi-asserted-by":"crossref","first-page":"196ra99","DOI":"10.1126\/scitranslmed.3005747","article-title":"MTORC1 inhibition is required for sensitivity to PI3K p110\u03b1 inhibitors in PIK3CA-mutant breast cancer","volume":"5","author":"Elkabets","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2023.101002_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cels.2021.04.002","article-title":"Deciphering the signaling network of breast cancer improves drug sensitivity prediction","volume":"12","author":"Tognetti","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2023.101002_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13058-016-0697-1","article-title":"Activation of IGF1R\/p110\u03b2\/AKT\/mTOR confers resistance to \u03b1-specific PI3K inhibition","volume":"18","author":"Leroy","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S1470-2045(18)30497-2","article-title":"Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial","volume":"19","author":"Dummer","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2023.101002_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1101\/gr.169508.113","article-title":"ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs","volume":"24","author":"Balwierz","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib42","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41388-018-0582-8","article-title":"The ERK and JNK pathways in the regulation of metabolic reprogramming","volume":"38","author":"Papa","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2023.101002_bib43","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ncb2629","article-title":"ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect","volume":"14","author":"Yang","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101002_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","article-title":"Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis","volume":"4","author":"Parmenter","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101002_bib45","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.xcrm.2023.101002_bib46","doi-asserted-by":"crossref","first-page":"e37699","DOI":"10.1371\/journal.pone.0037699","article-title":"Mitochondrial structure, function and dynamics are temporally controlled by c-Myc","volume":"7","author":"Graves","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101002_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2018.00129","article-title":"The role for myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues","volume":"9","author":"Goetzman","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.xcrm.2023.101002_bib48","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3892\/ol.2012.931","article-title":"Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients","volume":"4","author":"Zitka","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.xcrm.2023.101002_bib49","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2023.101002_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/annonc\/mdy497","article-title":"Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer","volume":"30","author":"Sokol","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2023.101002_bib51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/1541-7786.MCR-19-1201","article-title":"Inactivation of NF1 promotes resistance to EGFR inhibition in KRAS\/NRAS\/BRAFV600-wild-type colorectal cancer","volume":"18","author":"Stewart","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib52","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/2159-8290.CD-12-0470","article-title":"A genome-Scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition","volume":"3","author":"Whittaker","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101002_bib53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/2159-8290.CD-13-0741","article-title":"Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer","volume":"4","author":"de Bruin","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101002_bib54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/1535-7163.MCT-13-0817","article-title":"Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss","volume":"13","author":"Beauchamp","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2023.101002_bib55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cell.2010.06.004","article-title":"NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome","volume":"142","author":"H\u00f6lzel","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101002_bib56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12935-020-01570-8","article-title":"Advancement in research and therapy of NF1 mutant malignant tumors","volume":"20","author":"Tao","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.xcrm.2023.101002_bib57","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/bcr2419","article-title":"PD 0332991, a selective cyclin D kinase 4\/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in\u00a0vitro","volume":"11","author":"Finn","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF1 tumor suppressor gene function: Narrowing the GAP","volume":"104","author":"Cichowski","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101002_bib59","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41556-018-0169-1","article-title":"RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-NF1- and RAS-driven cancers","volume":"20","author":"Nichols","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101002_bib60","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.18632\/oncotarget.2194","article-title":"The NF1 gene revisited -from bench to bedside","volume":"5","author":"Yap","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2023.101002_bib61","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/hmg\/7.8.1261","article-title":"Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1 (NF1)","volume":"7","author":"Klose","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2023.101002_bib62","doi-asserted-by":"crossref","first-page":"e51436","DOI":"10.15252\/embr.202051436","article-title":"MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction","volume":"22","author":"Pathria","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.xcrm.2023.101002_bib63","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1101\/gad.836800","article-title":"Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability","volume":"14","author":"Sears","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2023.101002_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.onc.1201520","article-title":"Regulation of c-myc expression by Ras\/Raf signalling","volume":"16","author":"Kerkhoff","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2023.101002_bib65","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1128\/MCB.25.14.6225-6234.2005","article-title":"Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis","volume":"25","author":"Li","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101002_bib66","doi-asserted-by":"crossref","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","article-title":"The mechanism of action of N-acetylcysteine (NAC): the emerging role of H2S and sulfane sulfur species","volume":"228","author":"Pedre","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2023.101002_bib67","doi-asserted-by":"crossref","first-page":"14737","DOI":"10.1073\/pnas.2434516100","article-title":"Redox regulation of surface protein thiols: identification of integrin \u03b1-4 as a molecular target by using redox proteomics","volume":"100","author":"Laragione","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101002_bib68","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","article-title":"The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid","volume":"6","author":"Aruoma","year":"1989","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.xcrm.2023.101002_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00609183","article-title":"Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration","volume":"36","author":"Burgunder","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.xcrm.2023.101002_bib70","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-019-1056-z","article-title":"Genomic characterization of metastatic breast cancers","volume":"569","author":"Bertucci","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101002_bib71","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1158\/1078-0432.CCR-18-4044","article-title":"Inactivating NF1 mutations are enriched in advanced breast cancer and contribute to endocrine therapy resistance","volume":"26","author":"Pearson","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib72","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccell.2020.02.003","article-title":"Neurofibromin is an estrogen receptor-\u03b1 transcriptional Co-repressor in breast cancer","volume":"37","author":"Zheng","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101002_bib73","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","article-title":"Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients","volume":"185","author":"Nguyen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101002_bib74","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101002_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2023.101002_bib76","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101002_bib77","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/gene.10097","article-title":"Targeting mammary epithelial cells using a bacterial artificial chromosome","volume":"33","author":"Wintermantel","year":"2002","journal-title":"Genesis"},{"key":"10.1016\/j.xcrm.2023.101002_bib78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nprot.2016.164","article-title":"Genome-wide transposon screening and quantitative insertion site sequencing for cancer gene discovery in mice","volume":"12","author":"Friedrich","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2023.101002_bib79","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nsmb.3419","article-title":"RNA fate determination through cotranscriptional adenosine methylation and microprocessor binding","volume":"24","author":"Knuckles","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.xcrm.2023.101002_bib80","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2023.101002_bib81","doi-asserted-by":"crossref","first-page":"e92444","DOI":"10.1371\/journal.pone.0092444","article-title":"ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays","volume":"9","author":"Guzm\u00e1n","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101002_bib82","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib83","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/acs.jproteome.6b00753","article-title":"Robust, sensitive, and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons","volume":"16","author":"Post","year":"2017","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib84","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/acs.jproteome.6b00066","article-title":"Evaluation and improvement of quantification accuracy in isobaric mass tag-based protein quantification experiments","volume":"15","author":"Ahrn\u00e9","year":"2016","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib85","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib86","first-page":"1438","article-title":"From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline","volume":"5","author":"Chen","year":"2016","journal-title":"F1000Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib87","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101002_bib88","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/bioinformatics\/btu781","article-title":"QuasR: quantification and annotation of short reads in R","volume":"31","author":"Gaidatzis","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101002_bib89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101002_bib90","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","article-title":"A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology","volume":"3","author":"Guillen","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2023.101002_bib91","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ng.3741","article-title":"A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors","volume":"49","author":"Park","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2023.101002_bib92","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nature15260","article-title":"Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells","volume":"526","author":"Lawson","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101002_bib93","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/pmic.201000722","article-title":"Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells","volume":"11","author":"Wang","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.xcrm.2023.101002_bib94","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1074\/mcp.M116.065524","article-title":"Extended multiplexing of tandem mass tags (TMT) labeling reveals age and high fat diet specific proteome changes in mouse epididymal adipose tissue","volume":"16","author":"Plubell","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.xcrm.2023.101002_bib95","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101002_bib96","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/nar\/gks461","article-title":"Camera: a competitive gene set test accounting for inter-gene correlation","volume":"40","author":"Wu","year":"2012","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912300112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912300112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:54:43Z","timestamp":1762988083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266637912300112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S266637912300112X"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101002","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetylcysteine overcomes NF1 loss-driven resistance to PI3K\u03b1 inhibition in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101002"}}